199 related articles for article (PubMed ID: 10219982)
21. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
Grigoriadis DE; Zaczek R; Pearsall DM; De Souza EB
Endocrinology; 1989 Dec; 125(6):3068-77. PubMed ID: 2555137
[TBL] [Abstract][Full Text] [Related]
22. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
Dautzenberg FM; Wille S
Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
[TBL] [Abstract][Full Text] [Related]
23. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
[TBL] [Abstract][Full Text] [Related]
24. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data.
Dieterich KD; Grigoriadis DE; De Souza EB
Endocrinology; 1994 Oct; 135(4):1551-8. PubMed ID: 7925116
[TBL] [Abstract][Full Text] [Related]
25. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid.
Liaw CW; Lovenberg TW; Barry G; Oltersdorf T; Grigoriadis DE; de Souza EB
Endocrinology; 1996 Jan; 137(1):72-7. PubMed ID: 8536644
[TBL] [Abstract][Full Text] [Related]
26. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish.
Pohl S; Darlison MG; Clarke WC; Lederis K; Richter D
Eur J Pharmacol; 2001 Nov; 430(2-3):193-202. PubMed ID: 11711031
[TBL] [Abstract][Full Text] [Related]
27. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
[TBL] [Abstract][Full Text] [Related]
28. Corticotropin-releasing factor-binding protein (CRF-BP) inhibits CRF- and urotensin-I-mediated activation of CRF receptor-1 and -2 in common carp.
Manuel R; Metz JR; Flik G; Vale WW; Huising MO
Gen Comp Endocrinol; 2014 Jun; 202():69-75. PubMed ID: 24769042
[TBL] [Abstract][Full Text] [Related]
29. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
Martinez V; Barquist E; Rivier J; Taché Y
Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant.
Dautzenberg FM; Higelin J; Wille S; Brauns O
Regul Pept; 2004 Sep; 121(1-3):89-97. PubMed ID: 15256278
[TBL] [Abstract][Full Text] [Related]
31. Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain.
Berger H; Heinrich N; Wietfeld D; Bienert M; Beyermann M
Br J Pharmacol; 2006 Dec; 149(7):942-7. PubMed ID: 17057757
[TBL] [Abstract][Full Text] [Related]
32. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.
Lovenberg TW; Liaw CW; Grigoriadis DE; Clevenger W; Chalmers DT; De Souza EB; Oltersdorf T
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):836-40. PubMed ID: 7846062
[TBL] [Abstract][Full Text] [Related]
33. The human neuroblastoma cell line, IMR-32, expresses functional corticotropin-releasing factor receptors.
Hogg JE; Myers J; Hutson PH
Eur J Pharmacol; 1996 Sep; 312(2):257-61. PubMed ID: 8894604
[TBL] [Abstract][Full Text] [Related]
34. A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor.
Valdenaire O; Giller T; Breu V; Gottowik J; Kilpatrick G
Biochim Biophys Acta; 1997 May; 1352(2):129-32. PubMed ID: 9199241
[TBL] [Abstract][Full Text] [Related]
35. Novel high-affinity photoactivatable antagonists of corticotropin-releasing factor (CRF) photoaffinity labeling studies on CRF receptor, type 1 (CRFR1).
Bonk I; Rühmann A
Eur J Biochem; 2000 May; 267(10):3017-24. PubMed ID: 10806401
[TBL] [Abstract][Full Text] [Related]
36. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.
Rühmann A; Bonk I; Lin CR; Rosenfeld MG; Spiess J
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15264-9. PubMed ID: 9860957
[TBL] [Abstract][Full Text] [Related]
37. Expression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage-dependent regulation of functional receptors.
Gutknecht E; Hauger RL; Van der Linden I; Vauquelin G; Dautzenberg FM
J Neurochem; 2008 Feb; 104(4):926-36. PubMed ID: 17976162
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of multiple corticotropin-releasing factor type 2 receptor isoforms in the rat esophagus.
Wu SV; Yuan PQ; Wang L; Peng YL; Chen CY; Taché Y
Endocrinology; 2007 Apr; 148(4):1675-87. PubMed ID: 17218420
[TBL] [Abstract][Full Text] [Related]
39. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor.
Kostich WA; Chen A; Sperle K; Largent BL
Mol Endocrinol; 1998 Aug; 12(8):1077-85. PubMed ID: 9717834
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
